BioSpace News Archive

Pharm Country

Physicians’ Education Resource® to Present 9 Satellite Symposia at 2019 ASCO Annual Meeting

Physicians’ Education Resource® (PER®), a worldwide leading resource for continuing medical education (CME), will host nine CME-accredited satellite symposia adjunct to the 2019 ASCO (American Society of Clinical Oncology) Annual Meeting

May 16, 2019
·
9 min read
Business

Indivumed and Gnosis Partner to add Artificial Intelligence Capabilities to Indivumed’s Platform for Multi-Omics Cancer Research

Indivumed, a physician-led, integrated global oncology solution provider, announced today its partnership with Gnosis Data Analysis, a leading provider of automated Machine Learning and data-analytics solutions

May 16, 2019
·
3 min read
Business

Versant Health gives $100,000 to Vision To Learn, helps children receive Medicaid vision benefits

When children don’t see well, it’s hard for them to learn. Versant Health wants to help with the solution.

May 16, 2019
·
2 min read
Business

Taro to Announce Full Year Results on May 22, 2019

Taro Pharmaceutical Industries Ltd. (NYSE: TARO) announced today that it plans to release its financial results for year ended March 31, 2019, on Wednesday, May 22, 2019.

May 16, 2019
·
1 min read
Pharm Country

Azura Vascular Care brand rolls out in Northeast Florida

American Access Care of Jacksonville today announced that, as part of a phased brand rollout, it will now be known as Azura Vascular Care Jacksonville.

May 16, 2019
·
2 min read
BioCapital

ACRO Offers Unique Insights on Risk-Based Monitoring of Clinical Trials, and Calls for Adoption of RBM as a Best Practice

Following meetings with then-Commissioner Scott Gottlieb and senior leadership from the Center for Drug Evaluation and Research on the role of CROs and technology companies in designing and implementing risk-based monitoring (RBM) of clinical trials, the Association of Clinical Research Organizations (ACRO) this week submitted extensive comments on recent FDA Guidance.

May 16, 2019
·
2 min read
Biotech Bay

New Data from First-in-Human Study of RheOx™ Device-Based Therapy for Chronic Bronchitis to be Presented at ATS 2019

Gala Therapeutics, Inc. (Gala), a clinical-stage developer of medical devices to treat pulmonary disease, today announced that data from the first-in-human study of its investigational RheOxTM device will be presented at the 2019 American Thoracic Society (ATS) International Conference, occurring May 17-22, 2019 in Dallas, Texas.

May 16, 2019
·
2 min read
Deals

CEN Biotech Inc. announces a Merger Agreement with CSOC

On May 15, 2019, CEN Biotech, Inc. entered into a Non-Binding Term Sheet with Caduceus Software Systems Corp., a Wyoming corporation, which was reviewed and approved by the Board of Directors of CEN on May 15, 2019.

May 16, 2019
·
3 min read
Deals

Egalet Reports First Quarter 2019 Financial Results and Plan to Change Company Name to Zyla Life Sciences

Egalet Corporation reported financial results for the first quarter ended March 31, 2019 and announced it will change its name to Zyla Life Sciences in the coming weeks.

May 16, 2019
·
9 min read
Business

ResMed Elects Jan De Witte to Its Board of Directors

De Witte’s 30+ years of global healthcare and technology experience will bolster ResMed’s board capabilities

May 16, 2019
·
3 min read